Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
287
287 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- TCC1727Phase 22 trials
Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)
- TNO155Phase 22 trials
Novartis · Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation, KRAS G12C Mutant Solid Tumors
- ABT-101DBPR112Phase 21 trial
Anbogen Therapeutics, Inc. · Advanced Solid Tumor, Non Small Cell Lung Cancer, HER2 Mutations
- adebeliizumabPhase 21 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer
- AFNT-211Phase 21 trial
Affini-T Therapeutics, Inc. · Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, Colorectal Cancer
- ALK202Phase 21 trial
Shanghai Allink Biotherapeutics Co., Ltd. · NSCLC (Advanced Non-small Cell Lung Cancer)
- Alomnertinib MesilatePhase 21 trial
Shanghai Hengrui Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer
- and CarboplatinPhase 21 trial
CrystalGenomics, Inc. · Non Squamous Non Small Cell Lung Cancer
- ANS014004Phase 21 trial
Beijing Pearl Biotechnology Limited Liability Company · Non-Small Cell Lung Cancer, EGFR Mutation, Metastatic Lung Cancer
- ANS02Phase 21 trial
Avistone Biotechnology Co., Ltd. · Non-Small Cell Lung Cancer
- AP203Phase 21 trial
AP Biosciences Inc. · Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)
- ATX-295Phase 21 trial
Accent Therapeutics · Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer
- AU-007Phase 21 trial
Aulos Bioscience, Inc. · Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma
- AZD6750Phase 21 trial
AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)
- AZD7789Phase 21 trial
AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer
- AZD8205Phase 21 trial
AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer
- BBT-207Phase 21 trial
Bridge Biotherapeutics, Inc. · EGFR Mutant Advanced Non-Small Cell Lung Cancer
- BH-30643Phase 21 trial
BlossomHill Therapeutics · NSCLC (Advanced Non-small Cell Lung Cancer)
- BI-1910Phase 21 trial
BioInvent International AB · Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma
- BLU-924SAR449336Phase 21 trial
Blueprint Medicines Corporation · Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms
- BMS-986523Phase 21 trial
Bristol Myers Squibb · Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
- BNT116Phase 21 trial
Regeneron · Advanced Non-Small Cell Lung Cancer
- BPI-572270Phase 21 trial
Betta Pharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)
- CBX-12Phase 21 trial
Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma
- CKD-703Phase 21 trial
Chong Kun Dang Pharmaceutical · Advanced Solid Tumors, Non-Small Cell Lung Cancer
- CP-383Phase 21 trial
Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )
- CR-002Phase 21 trial
Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)
- DanvatirsenAZD9150Phase 21 trial
AstraZeneca · Non-Small Cell Lung Cancer
- Decoy20Phase 21 trial
Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)
- DS-1103aPhase 21 trial
Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
- EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial
NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer
- ENV-501Phase 21 trial
Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
- ES102Phase 21 trial
Elpiscience (Suzhou) Biopharma, Ltd. · Non-Small Cell Lung Cancer
- ETX-929Phase 21 trial
Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer
- FF-10832Gemcitabine LiposomePhase 21 trial
Fujifilm Pharmaceuticals U.S.A., Inc. · Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer
- gavo-celPhase 21 trial
TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura
- GEN-725Phase 21 trial
Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer
- GEN1042Phase 21 trial
Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
- GFH925Phase 21 trial
Genfleet Therapeutics (Shanghai) Inc. · Advance Non-small Cell Lung Cancer
- GI-101Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer
- GI-101APhase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer
- GI-108Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)
- GTAEXS617REC-617Phase 21 trial
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)
- HMBD-001Phase 21 trial
Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma
- IAM1363Phase 21 trial
Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer
- IDE397Phase 21 trial
Amgen · MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors
- IDP-001Phase 21 trial
InduPro, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma
- ILKN421HPhase 21 trial
iLeukon Therapeutics, Inc. · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- IMT-009Phase 21 trial
Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer
- INV-8989Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.